Compare Royal Bank of Canada (RY) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royal Bank of Canada vs 10X Genomics Inc — how do they compare? Royal Bank of Canada trades at $210.37 (market cap $289.51B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Royal Bank of Canada is far larger — about 52.8× 10X Genomics Inc's market cap, and Royal Bank of Canada pays a 2.42% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| RY | TXG | |
|---|---|---|
Market Cap | $289.51B | $5.48B |
Sector | Financials | Health |
52-Week High | $217.87 | $45.80 |
52-Week Low | $128.46 | $11.34 |
Dividend Yield | 2.42% | — |
Enterprise Value | — | $5.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
